At the time of writing, Medline Inc [MDLN] stock is trading at $42.72, up 5.43%. An important factor to consider is whether the stock is rising or falling in short-term value.
From an analyst’s perspective:
Medline Inc [NASDAQ: MDLN] stock has seen the most recent analyst activity on January 12, 2026, when Wolfe Research initiated its Outperform rating and assigned the stock a price target of $47. On January 12, 2026, Wells Fargo initiated with a Equal Weight rating and assigned a price target of $42 on the stock. UBS started tracking the stock assigning a Buy rating and suggested a price target of $48 on January 12, 2026. Truist initiated its recommendation with a Buy and recommended $52 as its price target on January 12, 2026. TD Cowen started tracking with a Buy rating for this stock on January 12, 2026, and assigned it a price target of $46. In a note dated January 12, 2026, Stifel initiated a Buy rating and provided a target price of $46 on this stock.
For the past year, the stock price of Medline Inc fluctuated between $34.89 and $45.50. Currently, Wall Street analysts expect the stock to reach $46.85 within the next 12 months. Medline Inc [NASDAQ: MDLN] shares were valued at $42.72 at the most recent close of the market. An investor can expect a potential return of 9.67% based on the average MDLN price forecast.
Analyzing the MDLN fundamentals
According to Medline Inc [NASDAQ:MDLN], the company’s sales were 27.43B for trailing twelve months, which represents an 11.38% jump. Gross Profit Margin for this corporation currently stands at 0.24% with Operating Profit Margin at 0.09%, Pretax Profit Margin comes in at 0.05%, and Net Profit Margin reading is 0.05%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.04 and Total Capital is 0.04. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.97.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Medline Inc [NASDAQ:MDLN] has a current ratio of 3.66. On the other hand, the Quick Ratio is 1.84, and the Cash Ratio is 0.37. Considering the valuation of this stock, the price to sales ratio is 1.26, the price to book ratio is 2.04 and price to earnings (TTM) ratio is 26.99.
Transactions by insiders
Recent insider trading involved Hellman & Friedman Capital Par, 10% Owner, that happened on Dec 18 ’25 when 6.09 million shares were sold. 10% Owner, GIC Private Ltd completed a deal on Dec 18 ’25 to buy 12.59 million shares. Meanwhile, 10% Owner GIC Private Ltd sold 10.2 million shares on Dec 18 ’25.
